Please join Foley for the next program in our Eye on China Roundtable Series, during which seasoned professionals from Foley and an economist from Charles River Associates will share recent experiences in this area and discuss the changing landscape and implications of M&A review for international transactions.
Specific topics to be addressed include:
- Solving the China puzzle in global M&A transactions
- Understanding the issues that trigger an M&A review by China
- An insider’s view of China’s M&A review agency, MOFCOM
- Practical tips for working more effectively with Chinese regulatory agencies
Moderator:
- Adria Warren, Senior Counsel, International Business Practice and Transactional & Securities Practice, Foley & Lardner LLP
Speakers:
- Linda Ji, Vice Chair, China Practice; Senior Counsel, International Business Practice and Transactional & Securities Practice, Foley & Lardner LLP
- Dr. Elizabeth Wang, Principal, Antitrust & Competition Economics Practice, Charles River Associates
Co-Sponsor:
This luncheon is complimentary. However, due to seating limitations, registration is on a first-come, first-served basis. For more information, contact Delia Dai at [email protected] or 312.832.4506.
To obtain any of the materials presented during the program, please contact Linda Ji at [email protected].
People
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.